Consolidated Note 2025 2024 $ $ Cash flows from operating activities Payments to suppliers and employees (8,096,985) (6,713,004) Interest received 8,502 6,930 Receipt from R&D tax rebate 2,337,618 6,052,925 (5,750,865) (653,149) Interest and other finance costs paid (73,733) (31,161) Net cash used in operating activities 23 (5,824,598) (684,310) Cash flows from investing activities Proceeds from release of security deposits 2,475,186 - Net cash from investing activities 2,475,186 - Cash flows from financing activities Proceeds from related party borrowings - 2,000,000 Repayment of related party borrowings - (2,000,000) Proceeds from issue of convertible note facility 2,600,000 - Proceeds from short term borrowings 1,800,000 - Repayment of short term borrowings (1,800,000) - Net cash used in financing activities 2,600,000 - Net decrease in cash and cash equivalents (749,412) (684,310) Cash and cash equivalents at the beginning of the financial year 2,319,927 3,008,674 Effects of exchange rate changes on cash and cash equivalents (16,341) (4,437) Cash and cash equivalents at the end of the financial year 1,554,174 2,319,927 Statement of cash flows For the year ended 30 June 2025 Annual Report 2025 28
RkJQdWJsaXNoZXIy MjE2NDg3